#drug pricing
10 stories
Trump's Medicaid drug deal claims lack detail
The administration projects $64 billion in savings from pharmaceutical deals, but experts say key details remain unclear and the claims overstate the impact.
FactCheck.org · 4m
Cancer Drugs Get 30% Trade Margin Cap
Experts finalize cancer drugs list under 30% trade margin cap to save ₹2,500 crore annually.
The Economic Times · 1m
Supreme Court Questions Govt on Drug Pricing Cap
Supreme Court asks why drug price cap limits anti-cancer medicines only.
The Economic Times · 1m
Germany must turn pharma promises into law
Roche argues Germany's conflicting signals on drug innovation are driving investment and research elsewhere, threatening medical supply and sovereignty.
POLITICO · 2m
Novartis and Eli Lilly Oppose India Breast Cancer Drug Price Cut Bid
Novartis and Eli Lilly oppose Kerala HC's bid to lower breast cancer drug prices in India, citing high global sales versus minimal local revenue.
The Economic Times · 1m
Trump Announces All 50 States Join Medicaid Drug Pricing Model
Trump announces all 50 states will adopt Medicaid drug pricing model to lower prescription costs.
Seattletimes · 1m
Pharma's patent pile-up keeps drug prices high
Drug makers are filing far more patents on minor tweaks to medicines, delaying cheaper generics and extending monopoly pricing without real innovation.
Ars Technica · 1m
CVS Shares Trade Below Wall Street Targets
CVS Health stock trades near $94, 19% below analyst target and 50% below model's $141 base case
Yahoo Finance · 1m
Trump announces all 50 states join Medicaid drug pricing deal
The administration claims billions in savings from a new program linking U.S. drug prices to other wealthy nations, but details remain secret.
ABC News · 1m
Trump's secret drug deals leave savings unclear
The administration claims billions in Medicaid savings, but won't reveal the details of its pharmaceutical agreements.
Fortune · 1m